Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit

J. L. Lopez-Campos, M. Roberts, F. Pozo-Rodriguez, S. Hartl (Seville, Madrid, Spain; London, United Kingdom; Vienna, Austria)

Source: Annual Congress 2013 –Guidelines and exacerbations
Session: Guidelines and exacerbations
Session type: Oral Presentation
Number: 172
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. L. Lopez-Campos, M. Roberts, F. Pozo-Rodriguez, S. Hartl (Seville, Madrid, Spain; London, United Kingdom; Vienna, Austria). Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit. Eur Respir J 2013; 42: Suppl. 57, 172

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015


GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study
Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2014

Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014


Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Exacerbations and healthcare resource utilization among COPD patients in Sweden
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013